Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
TSTL

Tristel plc

TSTLLSEUnited KingdomHealthcareMedical Instruments & SuppliesFTSE AIM 100

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other.…more

P/E24.91xP/B5.67xROIC26.2%Dividend yield3.5%
£191.32M
Market Cap
EV: £183.51M
MOM5
QUAL10
VAL4
RSK3
TSTL
£191.32M
Market Cap · EV £183.51M

Tristel plc

MOM5
QUAL10
VAL4
RSK3

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other.…more

Latest RNS from Tristel plc

Analyst consensus: Buy

As of 22 Jul 2026, 5 analysts rate Tristel plc a Buy, with 80% buy ratings and a mean price target of 475p (range 400p–560p), +23% vs the current price.

Strong buy: 0Buy: 4Hold: 1Sell: 0Strong sell: 0

Full analyst history →

Valuation vs peers

Peer-relative fair value estimate: 252p against a current price of 390p (-35%), based on EV/EBITDA.

More Healthcare companies